Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center. McGhie A, Lee J, Ferrajoli A, DiPippo AJ, et al. Leuk Lymphoma 2023;64:1050-1053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McGhie A, Lee J, Ferrajoli A, DiPippo AJ, et al. Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center. Leuk Lymphoma 2023;64:1050-1053.
PMID: 36891585